chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Asthenia, Cold sweat, Dizziness, Headache
Clinical narrative: severe stomach pains; bad headache; dizzy; Didn't have any energy and strength; Cold sweats; Nauseous; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 20Jan2021 at 02:45 PM as a single dose for COVID-19 immunisation, lot number: EL3247. Medical history included chronic lyme disease. Concomitant medications were not provided. Patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 23Jan2021 at 12:00 AM patient had severe stomach pains with a bad headache. Shortly after she got dizzy, did not have any energy and strength. She had cold sweats. Patient tried sips of water, but it made her nauseous. This all happened all at once and it hit patient hard in the middle of her work. No treatment received for the events. Since the vaccination patient had not been tested for COVID-19. Patient was recovering from the events.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: severe stomach pains; bad headache; dizzy; Didn't have any energy and strength; Cold sweats; Nauseous; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Left arm on 20Jan2021 at 02:45 PM as a single dose for COVID-19 immunisation, lot number: EL3247. Medical history included chronic lyme disease. Concomitant medications were not provided. Patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 23Jan2021 at 12:00 AM patient had severe stomach pains with a bad headache. Shortly after she got dizzy, did not have any energy and strength. She had cold sweats. Patient tried sips of water, but it made her nauseous. This all happened all at once and it hit patient hard in the middle of her work. No treatment received for the events. Since the vaccination patient had not been tested for COVID-19. Patient was recovering from the events.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chills, Fatigue, Gait disturbance
Clinical narrative: stomach pain, nausea pain, swelling, redness at injection site fever, chills legs, ankles and feet hurt when walking fatigue
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Nausea, Pain in extremity
Clinical narrative: stomach pain, nausea pain, swelling, redness at injection site fever, chills legs, ankles and feet hurt when walking fatigue
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Eye swelling, Periorbital swelling
Clinical narrative: Roughly 90 minutes after my vaccination my left eye got itchy and swollen; Roughly 90 minutes after my vaccination my left eye got itchy and swollen. Both the eye itself and the area around the eye swelled; the eye was still a bit puffy and swollen; This is a spontaneous report from a contactable healthcare professional (patient herself). A 25-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL8983; expiry date: unknown) via an unspecified route of administration in the left arm, on 22Jan2021 at 17:00, at a single dose, for COVID-19 immunization. The patient has no relevant medical history. Concomitant medications included vitamin B complex (VITAMIN B), colecalciferol (VITAMIN D), and loratadine (CLARITIN) and unspecified birth control (BC) pills. The patient previously received codeine and experienced allergy. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the hospital. On 22Jan2021, roughly 90 minutes after vaccination (at 18:30) the patient's left eye got itchy and swollen. Both eyes and the area around the eye swelled. It went down upon icing and taking two over the counter Benadryl. However, the next morning, the eye was still a bit puffy and swollen. The events were considered non-serious. Outcome of the events was recovering. The patient has not been tested for COVID-19 since vaccination.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Raised, red rash over trunk, arms, scalp; This is a spontaneous report from a contactable other hcp.   A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EK923), at single dose into the left arm on 30Dec2020 at 03:45 PM for COVID-19 immunization. The patient medical history was not reported.  Concomitant medication included diphenhydramine hydrochloride (BENADRYL) 25g and gabapentin 300mg. On 31Dec2020 at 06:00 PM the patient experienced raised, red rash over trunk, arms, scalp.  The outcome of the event was recovered.  It was reported that the patient received the second dose of BNT162B2 on 20Jan2021 at 07:45 AM in the Left arm.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Nausea, Pain
Clinical narrative: Fever; chills; nausea; body aches; headache; sore arm where injection was done; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 32-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3249), intramuscular on 21Jan2021 11:15 AM at single dose in right arm for COVID-19 immunisation. Patient age at vaccination was 32 years. The patient was vaccinated at workplace clinic. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 9231) intramuscular on 31Dec2020 06:30 PM, at single dose in left arm. The patient has no allergies to medications, food, or other products and had no relevant medical history. Concomitant medications included celecoxib (CELEXA), zonisamide (ZONEGRAN), loperamide hydrochloride (MEDIUM). On 21Jan2021 at 03:00 AM (as reported pending clarification) the patient experienced fever, chills, nausea, body aches, headache, sore arm where injection was done. The events were reported as non serious. No treatment was received for the events. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Fever; chills; nausea; body aches; headache; sore arm where injection was done; This is a spontaneous report from a contactable healthcare professional reporting for herself. A 32-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3249), intramuscular on 21Jan2021 11:15 AM at single dose in right arm for COVID-19 immunisation. Patient age at vaccination was 32 years. The patient was vaccinated at workplace clinic. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: 9231) intramuscular on 31Dec2020 06:30 PM, at single dose in left arm. The patient has no allergies to medications, food, or other products and had no relevant medical history. Concomitant medications included celecoxib (CELEXA), zonisamide (ZONEGRAN), loperamide hydrochloride (MEDIUM). On 21Jan2021 at 03:00 AM (as reported pending clarification) the patient experienced fever, chills, nausea, body aches, headache, sore arm where injection was done. The events were reported as non serious. No treatment was received for the events. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Decreased appetite, Injection site pain, Injection site swelling
Clinical narrative: CHILLS, LETHARGY, LOSS OF APPETITE, LOWER BACK PAIN, INJECTION SITE PAIN/SWELLING, SLIGHT DECREASE IN BREAST MILK PRODUCTION. I TESTED POSITIVE FOR COVID END OF OCTOBER AND REMAINED ASYMPTOMATIC. I HAD A WORSE REACTION TO THE FIRST DOSE OF VACCINE GIVEN 3 MONTHS LATER THAN ACTUAL COVID.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy
Clinical narrative: CHILLS, LETHARGY, LOSS OF APPETITE, LOWER BACK PAIN, INJECTION SITE PAIN/SWELLING, SLIGHT DECREASE IN BREAST MILK PRODUCTION. I TESTED POSITIVE FOR COVID END OF OCTOBER AND REMAINED ASYMPTOMATIC. I HAD A WORSE REACTION TO THE FIRST DOSE OF VACCINE GIVEN 3 MONTHS LATER THAN ACTUAL COVID.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test positive
Clinical narrative: I needed up get the Pfizer vaccine on Dec 23, 2020 since I worked in a Long Term Care Facility in a remote village and was scheduled to receive the next vaccine on Jan 6, 2021. However, I was released from my job on Jan 1, 2021. On Jan 4th, 2021, I was flown to another city. I spent some time there. Then, on Jan 16th, 2021, I landed in another city and checked in to a hotel. The next day, I was tested for the Corona Virus via nasal swab. The following day, they called me and said my test came back positive and said I had to quarantine for 10 days. I had minor pneumonia symptoms, but I felt they were not bad enough for me to go to the hospital. My symptoms were gone in about 5 days. I left being quarantine on Jan 30th, 2021.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Inappropriate schedule of product administration, SARS-CoV-2 test
Clinical narrative: I needed up get the Pfizer vaccine on Dec 23, 2020 since I worked in a Long Term Care Facility in a remote village and was scheduled to receive the next vaccine on Jan 6, 2021. However, I was released from my job on Jan 1, 2021. On Jan 4th, 2021, I was flown to another city. I spent some time there. Then, on Jan 16th, 2021, I landed in another city and checked in to a hotel. The next day, I was tested for the Corona Virus via nasal swab. The following day, they called me and said my test came back positive and said I had to quarantine for 10 days. I had minor pneumonia symptoms, but I felt they were not bad enough for me to go to the hospital. My symptoms were gone in about 5 days. I left being quarantine on Jan 30th, 2021.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypogeusia, Myalgia, Nausea, Parosmia
Clinical narrative: Typical headaches; muscle aches; nausea; distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine.; distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine.; This is a spontaneous report from a contactable healthcare professional (patient). A 54-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), intramuscular in the right arm on 22Jan2021 12:15 at single dose for COVID-19 immunisation. Medical history included elevated blood pressure and allergy to raw walnuts and pecans. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was vaccinated at a hospital. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included biotin (BIOTIN), vitamin d nos (VITAMIN D NOS), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), fexofenadine, hydrochlorothiazide, lisinopril (LISINOPRIL/HCTZ), cetirizine. The patient previously took morphine and experienced drug hypersensitivity. On 23Jan2021 15:00, the patient experienced typical headaches, muscle aches, nausea, distorted sense of smell (rancid smell and altered smells) and sense of taste severely diminished at 24 hours after initial dose of vaccine. No treatment was received for the adverse events. Clinical outcome of the events was not recovered.  Information on the lot/batch number has been requested.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Lymph node pain, Lymphadenopathy, Myalgia
Clinical narrative: -visible lymph node swelling in neck on same side of neck; 4-5 lymph nodes extremely swollen and tender; swelling slowly improved but happened again about 4 hours after 2nd dose of vaccine as well. lymph nodes currently still swollen/visible but no longer tender- went to see PCP for this 1 week after 1st vaccine, determined to be likely related to vaccine  - after second dose had temp of 102.1, rigors, severe myalgias x 24 hours; did not seek medical care for this, just used tylenol w/ improvement of symptoms
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza like illness, Injection site pain, Nausea
Clinical narrative: Around 4pm I felt a heavy fatigue come over me.  By 6pm I had the chills, fever and nausea.  This along with random pain throughout my body continued throughout the night an into the early morning.  My arms at the site of the injection and around it was also painfully sore to the touch.  The fatigue and overall flu like symptoms lasted throughout the following day and into the evening.  I started to feel better around 7pm.  The fatigue lasted into the next day.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Around 4pm I felt a heavy fatigue come over me.  By 6pm I had the chills, fever and nausea.  This along with random pain throughout my body continued throughout the night an into the early morning.  My arms at the site of the injection and around it was also painfully sore to the touch.  The fatigue and overall flu like symptoms lasted throughout the following day and into the evening.  I started to feel better around 7pm.  The fatigue lasted into the next day.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol, Blood pressure measurement, Gait disturbance, Headache, Nausea
Clinical narrative: brainfuzz headache; Aches; woke up nauseous; wobbly Almost fell over twice. Had to steady self; This is a spontaneous report from a contactable consumer, the patient.  A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 19Jan2021 at 11:15 (at the age of 78-years-old) as a single dose for COVID-19 immunization.  Medical history included prostatitis, high blood pressure, and high cholesterol, all from unknown dates and unknown if ongoing. The patient previously had COVID-19 prior to the vaccination on an unknown date to an unknown date (not ongoing).  The patient did not have any allergies to medications, food, or other products.  Since the vaccination, the patient had not been tested for COVID-19. The patient was taking unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Jan2021 at 07:45, the patient experienced brainfuzz headache, aches, woke up nauseous, and wobbly (almost fell over twice and had to steady himself). The patient did not receive any treatment for the events. The clinical outcomes of brainfuzz headache, aches, nausea, and wobbly, were recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: brainfuzz headache; Aches; woke up nauseous; wobbly Almost fell over twice. Had to steady self; This is a spontaneous report from a contactable consumer, the patient.  A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 19Jan2021 at 11:15 (at the age of 78-years-old) as a single dose for COVID-19 immunization.  Medical history included prostatitis, high blood pressure, and high cholesterol, all from unknown dates and unknown if ongoing. The patient previously had COVID-19 prior to the vaccination on an unknown date to an unknown date (not ongoing).  The patient did not have any allergies to medications, food, or other products.  Since the vaccination, the patient had not been tested for COVID-19. The patient was taking unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Jan2021 at 07:45, the patient experienced brainfuzz headache, aches, woke up nauseous, and wobbly (almost fell over twice and had to steady himself). The patient did not receive any treatment for the events. The clinical outcomes of brainfuzz headache, aches, nausea, and wobbly, were recovering.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Tiredness; Injection site pain; This is a spontaneous report from a contactable consumer.   A 54-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL3247), at single dose into the right arm on 22Jan2021 at 09:30AM for COVID-19 immunization. The patient medical history was not reported. On 11Jan2021 the patient had a negative  nasal swab covid_test.  The patient did not receive any concomitant medications. On 23Jan2021 at 08:00AM the patient experienced tiredness and injection site pain. No treatment  was received. The outcome of the events was not recovered.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: experienced sudden onset of tinnitis mostly in my right ear, but both ears were affected.  It sounded like I was hearing a lot of echoing/tinny sound in my ears every time someone was talking; This is a spontaneous report from a contactable pharmacist (patient). A 38-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 14Jan2021 at 5:00PM at single dose in left arm for COVID-19 immunisation at the age of 38-year-old. Lot number was EL3249. Medical history and concomitant medications were unknown. The patient was not pregnant at the time of vaccination. The patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28Dec2020 at 1:00PM at single dose in left arm for COVID-19 immunisation (lot number was EL1284) at the age of 38-year-old. About 26 hours after 2nd dose of vaccine on 22Jan2021 at 7:00PM, the patient experienced sudden onset of tinnitis mostly in right ear, but both ears were affected.  It sounded like the patient was hearing a lot of echoing/ tinny sound in ears every time someone was talking.  It only lasted a few hours and hearing returned to normal, but the patient had never experienced anything like that before, and it was so close to the vaccine administration, that she had to wonder if there was a correlation. The patient was not treated for the event. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, she has not been tested for COVID-19. The patient recovered from the event. Information on the lot/batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Vertigo
Clinical narrative: I had significant vertigo lasting 5 days. This is on the CDC list to ?call your physician?.  I was not dizzy-by definition but vertiginous -trying to turn over in bed made my head feel like it was spinning. I think this is much more common than reported. As a physician in the community people frequently reach out to me for advice and I  have been told several times about serious  vertigo in elderly people with new onset after Covid immunization.  I have no intention to delay or abort my second dose. My only current symptoms is fuzzy headedness that is sporadic. The elderly might need to be warned about this and advised accordingly-re not to drive etc. i am former physician and after TNTC immunizations in the past this was unique.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Running nose; Fatigue; Drip-age that causes sore throat (starting day 2-3 after vaccination and is current).; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself.  A 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE on 15Jan2021 14:00 at single dose for covid-19 immunisation. Medical history included history of stroke and current depression, ongoing.  No allergy to medications, food, or other products. Concomitant medication included topiramate (TOPAMAX) and acetylsalicylic acid (ASPIRIN) and Celebs (as reported), all within 2 weeks of vaccination.  Patient was not pregnant and was not pregnant at the time of vaccination. On 15Jan2021 at 16:00 the patient experienced running nose and fatigue; she had "drip-age" that caused sore throat, starting day 2-3 after vaccination (Jan2021) and was current (as reported). No treatment given for the events. Fatigue last same day and 2 days after. Final outcome of running nose and fatigue was reported as unknown; outcome of the other event was not recovered. Information on the lot/batch number has been requested.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: The lymphnodes in my left armpit are swollen and tender; The lymphnodes in my left armpit are swollen and tender; This is a spontaneous report from a contactable consumer (patient).  This 36-year-old female patient (not pregnant) received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3302), via an unknown route, on 21Jan2021 (at 07:30 AM) at single dose on the left arm, for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL1284) administered on 31Dec2020 (at 06:45 AM) on the left arm. The patient was vaccinated at hospital, age at vaccination was 36-year-old. No other vaccine was received in four weeks. Pre-vaccination and post-vaccination COVID tests were not performed. No known allergies. On 22Jan2021 (at 06:00 AM), the patient stated 'the lymphnodes in my left armpit are swollen and tender'. The events were assessed as non-serious. No treatments were given for the events. The patient had not recovered from the events.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Very severe aching and fatigue
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dry mouth, Dyspnoea, Eye pain, Eye swelling
Clinical narrative: Piercing eye pain; Swollen/red left eye; Swollen/red left eye; Extreme photophobia; Body wide muscle pain; Fatigue; Increased dry mouth; GI upset; Nasal congestion; Wheezing; Shortness of breath; This is a spontaneous report from a contactable health care professional nurse, the patient. A 53-years-old non-pregnant female patient (nurse)  received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9262,), via an unspecified route of administration in left arm on 21Jan2021 at 16:45 as a single dose, for COVID-19 vaccination.  The most recent COVID-19 vaccine was administered at a Workplace clinic. Medical history included rheumatoid arthritis dry eye, hypertension, anxiety and asthma. Concomitant medication included lisinopril (LISINOPRIL), paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), iron (IRON), oxymetazoline hydrochloride (CLARITIN ALLERGIC), montelukast sodium (SINGULAIR). No other vaccines were given within 4 weeks. . Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient received the first  dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot Number:PFR-20364-01; in the right arm on 29Dec2020, at 09:00.  On 22Jan2021 at 05:00, the patient woke the day after at 5AM with piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath. No treatment was received given for the events. The clinical outcome of piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath was recovering.         Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No  Allergies to medications, food, or other products:no Vaccine Facility information available. Ethnicity information is available. Race information is available.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nasal congestion, Ocular hyperaemia, Photophobia
Clinical narrative: Piercing eye pain; Swollen/red left eye; Swollen/red left eye; Extreme photophobia; Body wide muscle pain; Fatigue; Increased dry mouth; GI upset; Nasal congestion; Wheezing; Shortness of breath; This is a spontaneous report from a contactable health care professional nurse, the patient. A 53-years-old non-pregnant female patient (nurse)  received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9262,), via an unspecified route of administration in left arm on 21Jan2021 at 16:45 as a single dose, for COVID-19 vaccination.  The most recent COVID-19 vaccine was administered at a Workplace clinic. Medical history included rheumatoid arthritis dry eye, hypertension, anxiety and asthma. Concomitant medication included lisinopril (LISINOPRIL), paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), iron (IRON), oxymetazoline hydrochloride (CLARITIN ALLERGIC), montelukast sodium (SINGULAIR). No other vaccines were given within 4 weeks. . Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient received the first  dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot Number:PFR-20364-01; in the right arm on 29Dec2020, at 09:00.  On 22Jan2021 at 05:00, the patient woke the day after at 5AM with piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath. No treatment was received given for the events. The clinical outcome of piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath was recovering.         Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No  Allergies to medications, food, or other products:no Vaccine Facility information available. Ethnicity information is available. Race information is available.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Piercing eye pain; Swollen/red left eye; Swollen/red left eye; Extreme photophobia; Body wide muscle pain; Fatigue; Increased dry mouth; GI upset; Nasal congestion; Wheezing; Shortness of breath; This is a spontaneous report from a contactable health care professional nurse, the patient. A 53-years-old non-pregnant female patient (nurse)  received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EL9262,), via an unspecified route of administration in left arm on 21Jan2021 at 16:45 as a single dose, for COVID-19 vaccination.  The most recent COVID-19 vaccine was administered at a Workplace clinic. Medical history included rheumatoid arthritis dry eye, hypertension, anxiety and asthma. Concomitant medication included lisinopril (LISINOPRIL), paroxetine hydrochloride (PAXIL [PAROXETINE HYDROCHLORIDE]), iron (IRON), oxymetazoline hydrochloride (CLARITIN ALLERGIC), montelukast sodium (SINGULAIR). No other vaccines were given within 4 weeks. . Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient received the first  dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot Number:PFR-20364-01; in the right arm on 29Dec2020, at 09:00.  On 22Jan2021 at 05:00, the patient woke the day after at 5AM with piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath. No treatment was received given for the events. The clinical outcome of piercing eye pain along with swollen/red left eye.  extreme photophobia. body wide muscle pain. fatigue. increased dry mouth. GI upset. nasal congestion. Wheezing. Shortness of breath was recovering.         Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No  Allergies to medications, food, or other products:no Vaccine Facility information available. Ethnicity information is available. Race information is available.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: A rash appeared two days after the 1st injection, mainly on stomach; This is a spontaneous report from a contactable nurse reporting for herself. A 28-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL0140), via an unspecified route of administration on 30Dec2020 07:00 AM at single dose in left arm for COVID-19 immunisation.  Patient age at time of vaccination was 28 years. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history included allergies to eggs, shellfish, peanuts. Concomitant medication included desogestrel, ethinylestradiol (APRI). On 01Jan2021 the patient experienced a rash appeared two days after the 1st injection, mainly on stomach. The event was reported as non serious and resulted in Doctor or other healthcare professional office/clinic visit. Treatment for the event included steroid cream. The event had not resolved. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has not been tested for COVID-19.
Sex: U
Vaccine: COVID19
Symptoms: Needle issue, Product contamination physical, Syringe issue
Clinical narrative: [COVID-19 Vaccine] treatment under Emergency Use Authorization(EUA): 1 mL 25G x 1" *(REF 10161, LOTG200926) used for the Pfizer BioNTech Covid-19 Vaccine for IM injection. While drawing up the first dose of the COVID vaccine in a reconstituted vial, a Pharmacist noticed a green particulate in the syringe. Uncertain of the origin of the particulate, the subsequent dose was not used. Instead, a filter needle with a 1 mL BD Leur Lock syringe was used to draw up remaining doses, then the filter needle was replaced with a 25G x 1" needle. None of the COVID-19 vaccine was affected, and the particulate did not appear to have originated from the stopper of the vaccine vial, as the stopper was grey in color, not green like the particulate found in the syringe. All previously drawn-up doses were inspected and none of the syringes contained particulates.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased
Clinical narrative: Blood sugar dropped from 219 to 50 within 30 minutes after vaccination.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Tremor
Clinical narrative: Headache; severe chills; severe shivering/shakes; This is a spontaneous report from a contactable healthcare professional (patient). A 26-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL9261), intramuscularly in the left arm, on 21Jan2021 10:30 (at the age of 26-years-old) at a single dose for COVID-19 immunization. Medical history included latex allergy. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications, taken within two weeks of vaccination, included ethinylestradiol, etynodiol diacetate (KELNOR) taken as a contraceptive and fexofenadine hydrochloride (ALLEGRA). The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL0142), intramuscularly in the left arm, on 31Dec2020 at 17:00 (at the age of 26-years-old) for COVID-19 immunization. The patient experienced headache, severe chills, and severe shivering/shakes on 21Jan2021 at 21:00. The events were reported as non-serious. The clinical course was reported as follows: Less than 12 hours after getting vaccinated, the patient experienced headache, severe chills, severe shivering/shakes that didn't stop. Being under blankets didn't help but using heating pad helped a lot. The shaking stopped the next morning, but patient still had a bit of chills and headache the next day. Therapeutic measures were taken as a result of the severe chills and severe shivering/shakes as aforementioned. The patient did not receive any treatment for headache as reported. The clinical outcome of headache and chill was recovering and of severe shivering/shakes was recovered on 22Jan2021. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspepsia, Inappropriate schedule of product administration, Lymph node pain, Lymphadenopathy, Pyrexia
Clinical narrative: FIrst dose was administered on 05Jan2021; Fever; Sore arm around injection site; swollen and sore lymph nodes: neck and arm of of injection; swollen and sore lymph nodes: neck and arm of of injection; Indigestion; This is a spontaneous report from a contactable 28-year-old female consumer reporting for herself   A 28 years old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El3300) on 22Jan2021 at 08:15 at single dose via an unspecified route of administration on right arm for COVID-19 immunization. Relevant medical history included Shellfish allergy and allergy to doxicicline. The patient received first dose of vaccine on 05Jan2021 at 03:00 PM on right arm, lot_number=Ej1685.  On 22Jan2021 at 18:00 the patient experienced fever, sore arm around injection site, swollen and sore lymph nodes: neck and arm of injection Indigestion (as reported). At the time of the reporting the patient had not yet recovered from reported events.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: FIrst dose was administered on 05Jan2021; Fever; Sore arm around injection site; swollen and sore lymph nodes: neck and arm of of injection; swollen and sore lymph nodes: neck and arm of of injection; Indigestion; This is a spontaneous report from a contactable 28-year-old female consumer reporting for herself   A 28 years old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: El3300) on 22Jan2021 at 08:15 at single dose via an unspecified route of administration on right arm for COVID-19 immunization. Relevant medical history included Shellfish allergy and allergy to doxicicline. The patient received first dose of vaccine on 05Jan2021 at 03:00 PM on right arm, lot_number=Ej1685.  On 22Jan2021 at 18:00 the patient experienced fever, sore arm around injection site, swollen and sore lymph nodes: neck and arm of injection Indigestion (as reported). At the time of the reporting the patient had not yet recovered from reported events.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity, Pyrexia
Clinical narrative: Fever; Arm pain; Fatigue; This is a spontaneous report from a non-contactable consumer.  A non-pregnant 22-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in the left arm on 21Jan2021, at 16:45 as single dose for covid-19 immunization.  The patient's medical history was not reported. There were unspecified concomitant medications; this was reported as antibiotics within two weeks of vaccination. No other vaccines were received within four weeks prior to the COVID vaccine.  On 22Jan2021, at 07:00, the patient experienced fever, arm pain and fatigue, which were non-serious. No treatment as received  for the events. Prior to vaccination, the patient  was not diagnosed with COVID-19, nor has the patient been tested for COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of experienced fever, arm pain and fatigue was not recovered.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Autopsy, Death
Clinical narrative: Patient died several days after receiving the second dose of the vaccine. See additional information sent. An autopsy has been performed and results are pending.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Neck pain
Clinical narrative: Headache; neck pain; shoulder pain; This is a spontaneous report from a contactable healthcare professional.  A 28-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 21Jan2021, at 10:30 as first single for covid-19 immunization.  Medical history included tonsillectomy, appendicectomy and gastric bypass on unknown dates and unknown if ongoing. No allergies to medications, food, or other products were noted. The patient received unspecified bariatric multivitamin within two weeks of vaccination; the patient did not receive any other vaccines within four weeks prior to the vaccine.  On 22Jan2021, at 09:00 patient experienced headache, neck pain and shoulder pain. The events were assessed as non-serious.   No therapeutic measures were taken as results of the events.  Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient  has not been tested for COVID-19. The outcome of  headache, neck pain and shoulder pain was not recovered.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: fatigue; slight body aches; This is a spontaneous report from a contactable nurse (the patient) via Pfizer sales representative. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fatigue and slight body aches on an unspecified date. The clinical outcome of the events fatigue and slight body aches was unknown.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation, Hypoaesthesia
Clinical narrative: numbness for an hour; burning sensation; joint pain; This is a spontaneous report from a non-contactable consumer reporting on behalf of the patient. A 49-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, unknown lot number and expiration), via an unspecified route of administration on 19Dec2020 at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced numbness for an hour, and subsequently burning sensation and joint pain which subsided with Tylenol use. The patient was recovering from the events burning sensation and joint pain, while unknown outcome for the remaining event.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Computerised tomogram abdomen, Full blood count, Metabolic function test, Nausea
Clinical narrative: Moderate abdominal pain beginning on Sunday evening.  The pain worsened throughout the day on Monday and became severe.  It was accompanied by nausea and vomiting  and made worse with food and water.   I went to the ER on Tuesday (2/2/21) morning.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Urine analysis, Vomiting
Clinical narrative: Moderate abdominal pain beginning on Sunday evening.  The pain worsened throughout the day on Monday and became severe.  It was accompanied by nausea and vomiting  and made worse with food and water.   I went to the ER on Tuesday (2/2/21) morning.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal lesion
Clinical narrative: small sore on vagina; This is a spontaneous report from a contactable nurse (patient).  A 24-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EH9899), intramuscular on 21Dec2020, at 16:00 as first single dose for covid-19 immunization.  The patient medical history was not reported.  Concomitant medication included ethinylestradiol, norgestimate (SPRINTEC).  The patient experienced a small sore on vagina on an unspecified date, after the vaccination. The outcome of small sore on vagina was recovered on an unspecified date.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Feeling abnormal, Gait inability, Impaired driving ability
Clinical narrative: Then the fever started and lasted 24 hours/It was 102.1 at its worst point on Tuesday afternoon/ Tuesday night around 9 my fever came back down to 99; hard time driving; EXTREME chills like never before in my life; So bad my body tensed up for hours; my body hurt so bad; couldn't walk; Vertigo; my ears and head feel like they are underwater; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot El8982) solution for injection intramuscular in the left arm on 18Jan2021 (at the age of 32-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included high blood pressure. Concomitant medication included metoprolol. The patient had no known allergies. Historical vaccine included BNT162B2 COVID 19, brand=Pfizer, lot number=Ej1686, 28Dec2020, intramuscular in left arm, dose 1, for COVID-19 vaccination and experienced extreme fatigue and headache. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 18Jan2021 at 20:00, the patient experienced hard time driving, extreme chills like never before in my life so bad my body tensed up for hours, my body hurt so bad, couldn't walk, vertigo and my ears and head feel like they are underwater. Then the fever started and lasted 24 hours/it was 102.1 at its worst point on 19Jan2021, Tuesday afternoon/Tuesday night around 9 my fever came back down to 99. No treatment was provided for the events hard time driving, chills, tensed up, fever, body hurt, couldn't walk, vertigo and my ears and head feel like they are underwater. The outcome of the events hard time driving, chills, tensed up, fever, body hurt, couldn't walk, vertigo and my ears and head feel like they are underwater was recovered with sequel in Jan2021. Since the vaccination, the patient has not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Tension, Vertigo
Clinical narrative: Then the fever started and lasted 24 hours/It was 102.1 at its worst point on Tuesday afternoon/ Tuesday night around 9 my fever came back down to 99; hard time driving; EXTREME chills like never before in my life; So bad my body tensed up for hours; my body hurt so bad; couldn't walk; Vertigo; my ears and head feel like they are underwater; This is a spontaneous report from a contactable healthcare professional, the patient. A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot El8982) solution for injection intramuscular in the left arm on 18Jan2021 (at the age of 32-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included high blood pressure. Concomitant medication included metoprolol. The patient had no known allergies. Historical vaccine included BNT162B2 COVID 19, brand=Pfizer, lot number=Ej1686, 28Dec2020, intramuscular in left arm, dose 1, for COVID-19 vaccination and experienced extreme fatigue and headache. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 18Jan2021 at 20:00, the patient experienced hard time driving, extreme chills like never before in my life so bad my body tensed up for hours, my body hurt so bad, couldn't walk, vertigo and my ears and head feel like they are underwater. Then the fever started and lasted 24 hours/it was 102.1 at its worst point on 19Jan2021, Tuesday afternoon/Tuesday night around 9 my fever came back down to 99. No treatment was provided for the events hard time driving, chills, tensed up, fever, body hurt, couldn't walk, vertigo and my ears and head feel like they are underwater. The outcome of the events hard time driving, chills, tensed up, fever, body hurt, couldn't walk, vertigo and my ears and head feel like they are underwater was recovered with sequel in Jan2021. Since the vaccination, the patient has not been tested for COVID-19.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rhinorrhoea
Clinical narrative: Having runny nose; Fatigue; This is a spontaneous report from a non-contactable consumer (patient). A female patient of an unspecified age received her first dose of bnt162b2 (BNT162B2 reported as COVID VACCINE; unknown lot number and expiration date), via an unspecified route of administration on Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she has been administered the first dose of COVID vaccine yesterday (Jan2021) and she reported having runny nose and fatigue all day. The representative reported it within 24 hours of his wife's persistent symptoms. The outcome of the events was not recovered.   No follow-up attempts are possible; Information about Lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness of injection site; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), via an unspecified route of administration in the right arm on 19Jan2021 at 06:15 P.M. (at the age of 28-years-old) as a single dose, dose 1 for COVID-19 vaccination. The patient had an allergy to nickel.  The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were unknown. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Jan2021 at 06:30 PM, the patient experienced soreness of injection site. The patient did not receive any treatment for the events. The clinical outcome of soreness of injection site was  not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.